Leo Pharma owner: "You can’t go public without a growth outlook or an interesting pipeline"
![Photo: Leo Pharma/PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13754818.ece/ALTERNATES/schema-16_9/doc7jth20wuc3q1f904zevm.jpg)
Several top managers have been replaced and the organization’s management looks markedly different from just a few years ago. The company is leaking money, and has announced that 1,000 positions are to be terminated.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Layoffs and restructuring will prepare Leo Pharma for IPO
For subscribers
Leo Pharma poaches Novo Nordisk VP to lead US division
For subscribers